| Non-alcoholic fatty liver disease in lean individuals S Albhaisi, A Chowdhury, AJ Sanyal JHEP Reports 1 (4), 329-341, 2019 | 154 | 2019 |
| Role of gut microbiota in liver disease SAM Albhaisi, JS Bajaj, AJ Sanyal American Journal of Physiology-Gastrointestinal and Liver Physiology, 2020 | 127 | 2020 |
| Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study DQ Huang, LA Wilson, C Behling, DE Kleiner, KV Kowdley, S Dasarathy, ... Gastroenterology 165 (2), 463-472. e5, 2023 | 82 | 2023 |
| Recent advances in understanding and managing non-alcoholic fatty liver disease S Albhaisi, A Sanyal F1000Research 7, 2018 | 61 | 2018 |
| New drugs for NASH SAM Albhaisi, AJ Sanyal Liver International 41, 112-118, 2021 | 49 | 2021 |
| Impact of antibiotic resistance genes in gut microbiome of patients with cirrhosis A Shamsaddini, PM Gillevet, C Acharya, A Fagan, E Gavis, M Sikaroodi, ... Gastroenterology 161 (2), 508-521. e7, 2021 | 46 | 2021 |
| The Influence of the Microbiome on NAFLD and NASH SAM Albhaisi, JS Bajaj Clinical liver disease 17 (1), 15-18, 2021 | 46 | 2021 |
| Small dense low‐density lipoprotein cholesterol predicts cardiovascular events in liver transplant recipients MB Siddiqui, T Arshad, S Patel, E Lee, S Albhaisi, AJ Sanyal, RT Stravitz, ... Hepatology 70 (1), 98-107, 2019 | 39 | 2019 |
| Current and potential therapies targeting inflammation in NASH S Albhaisi, M Noureddin Frontiers in endocrinology 12, 767314, 2021 | 34 | 2021 |
| Applying non-invasive fibrosis measurements in NAFLD/NASH: progress to date S Albhaisi, AJ Sanyal Pharmaceutical Medicine 33 (6), 451-463, 2019 | 28 | 2019 |
| Gene-environmental interactions as metabolic drivers of nonalcoholic steatohepatitis S Albhaisi, AJ Sanyal Frontiers in Endocrinology 12, 665987, 2021 | 26 | 2021 |
| Gut microbial signature of hepatocellular cancer in men with cirrhosis S Albhaisi, A Shamsaddini, A Fagan, S McGeorge, M Sikaroodi, E Gavis, ... Liver Transplantation 27 (5), 629-640, 2021 | 20 | 2021 |
| The relationship between hypoadiponectinemia and cardiovascular events in liver transplant recipients MB Siddiqui, S Patel, T Arshad, E Lee, S Albhaisi, C Driscoll, S Wolver, ... Transplantation 103 (11), 2323-2328, 2019 | 17 | 2019 |
| Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium JS Bajaj, AK Choudhury, Q Xie, PS Kamath, M Topazian, PC Hayes, ... The Lancet Gastroenterology & Hepatology 8 (7), 611-622, 2023 | 14 | 2023 |
| The prediction of in‐hospital mortality in decompensated cirrhosis with acute‐on‐chronic liver failure F Wong, KR Reddy, P Tandon, JC Lai, N Jagarlamudi, V Weir, B Kok, ... Liver Transplantation 28 (4), 560-570, 2022 | 14 | 2022 |
| The association between serum liver enzymes and cancer mortality S Albhaisi, R Qayyum Clinical and experimental medicine, 1-7, 2021 | 14 | 2021 |
| LPCN 1144 resolves NAFLD in hypogonadal males S Albhaisi, K Kim, J Baker, N Chidambaram, MV Patel, M Charlton, ... Hepatology Communications 4 (10), 1430-1440, 2020 | 14 | 2020 |
| Cognitive function in liver transplantation SAM Albhaisi, JS Bajaj Current transplantation reports 7, 31-37, 2020 | 13 | 2020 |
| The value of medical registries and observational studies early in pandemics: the coronavirus disease 2019 (COVID-19) experience S Albhaisi, RP Wenzel Clinical Infectious Diseases 74 (6), 1112-1116, 2022 | 10 | 2022 |
| Hospitalized women with cirrhosis have more non-hepatic comorbidities and associated complications than men JB Rubin, YT Srisengfa, S Albhaisi, C Acharya, G Nangia, T Shaikh, ... Clinical gastroenterology and hepatology: the official clinical practice …, 2020 | 9 | 2020 |
